PTC THERAPEUTICS, INC. — Director's Dealing 2021

Jan 7, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2021-01-05

Reporting Person: Pauwels Eric (Chief Business Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-01-05	Common Stock	S	289	$62.37	Disposed	27858	Direct
2021-01-05	Common Stock	S	778	$62.37	Disposed	27080	Direct

Footnotes

F1: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 825 shares of restricted stock from a January 3, 2017 grant of 3,300 shares of restricted stock.

F2: Includes 258 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending June 30, 2020 and 242 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2020.

F3: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 2,300 shares of restricted stock from a January 3, 2018 grant of 9,200 shares of restricted stock.